Search

Your search keyword '"Non-small cell lung cancer -- Reports -- Forecasts and trends"' showing total 86 results
Start Over Descriptor "Non-small cell lung cancer -- Reports -- Forecasts and trends"
86 results on '"Non-small cell lung cancer -- Reports -- Forecasts and trends"'

1. Research and Markets Offers Report: Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Arts and entertainment industries
Abstract

Research and Markets has announced the addition of the 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' report [...]

Published
2020

2. Global Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer Market - Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Subjects
Physical fitness -- Forecasts and trends -- Reports, Cancer -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Obesity, Anopheles, Non-Hodgkin's lymphomas, Tumors, Editors, Lung cancer, Diseases, Market trend/market analysis, Health
Abstract

2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- The 'Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology [...]

Published
2020

3. Global Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast 20202030

Subjects
Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, Oct 09, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been [...]

Published
2020

4. Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast 2030 by DelveInsight

Subjects
Durvalumab -- Reports -- Forecasts and trends, Business research -- Reports -- Forecasts and trends, Dacomitinib -- Reports -- Forecasts and trends, Atezolizumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Kinase inhibitors -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Antineoplastic agents -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 30, 2020-: Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast 2030 by DelveInsight (C)1994-2020 M2 COMMUNICATIONS RDATE:29092020 DelveInsight's 'Non-Small Cell Lung Cancer (NSCLC) - Market [...]

Published
2020

5. Global PD-1/PD-L1 Immunotherapy Market: Focus on Type, Application, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030

Subjects
Immunotherapy -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, Sep 18, 2020 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global PD-1/PD-L1 Immunotherapy Market: Focus on Type, Application, Country Data (14 Countries), and [...]

Published
2020

6. Global PD-L1 NSCLC Market: Insights, Epidemiology, Drugs and Players (2017-2030)

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

7. Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC) Market Insights and Forecasts, 2017-2030

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

8. Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC) Market Insights and Forecasts, 2017-2030 - ResearchAndMarkets.com

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN -- The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]

Published
2020

9. Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC) Market Insights and Forecasts, 2017-2030

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-August 4, 2020-: Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC) Market Insights and Forecasts, 2017-2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:04082020 The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung [...]

Published
2020

10. Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) Market, Size, Share, Trends, Epidemiology Forecast till 2030

Subjects
Durvalumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 21, 2020-: Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) Market, Size, Share, Trends, Epidemiology Forecast till 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:20072020 DelveInsight's 'Programmed death-ligand 1 (PD-L1) [...]

Published
2020

11. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market, Size, Share, Epidemiology, Forecast till 2030

Subjects
Osimertinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 17, 2020-: Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market, Size, Share, Epidemiology, Forecast till 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:16072020 DelveInsight's 'Epidermal Growth Factor Receptor-Non Small [...]

Published
2020

12. Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast 2030

Subjects
Durvalumab -- Reports -- Forecasts and trends, Business research -- Reports -- Forecasts and trends, Osimertinib -- Forecasts and trends -- Reports, Dabrafenib -- Reports -- Forecasts and trends, Atezolizumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Trametinib -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 16, 2020-: Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:15072020 DelveInsight's 'Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology [...]

Published
2020

13. Non-Small-Cell Lung Carcinoma (NSCLC) Epidemiology Forecast | Non-Small-Cell Lung Carcinoma (NSCLC) Prevalent population

Subjects
Business research -- Reports -- Forecasts and trends, Carcinoma -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 16, 2020-: Non-Small-Cell Lung Carcinoma (NSCLC) Epidemiology Forecast | Non-Small-Cell Lung Carcinoma (NSCLC) Prevalent population (C)1994-2020 M2 COMMUNICATIONS RDATE:15072020 DelveInsight's 'Non-Small-Cell Lung Carcinoma (NSCLC) - Epidemiology Forecast to [...]

Published
2020

14. Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030

Subjects
Merck KGaA -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Brigatinib -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Cobimetinib -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Cancer research -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Romiplostim -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Antineoplastic agents -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 15, 2020-: Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:14072020 DelveInsight's 'Non-Small [...]

Published
2020

15. ALK Non-Small Cell Lung Cancer Markets, Forecast to 2030 - Market Analysis, Pipeline, Epidemiology, Drug Sales & Shares by Country and Competition

Subjects
Drugs -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines has [...]

Published
2020

16. ALK Non-Small Cell Lung Cancer Industry Assessment 2017-2030

Subjects
Brigatinib -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Crizotinib -- Reports -- Forecasts and trends, Ceritinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Market trend/market analysis, Business, international, Law
Abstract

(GlobeNewswire) - The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]

Published
2020

17. ALK Non-Small Cell Lung Cancer Industry Assessment 2017-2030

Subjects
Brigatinib -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Crizotinib -- Reports -- Forecasts and trends, Ceritinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, July 03, Jul 03, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines [...]

Published
2020

18. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC) Markets to 2030

Subjects
Brigatinib -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Crizotinib -- Reports -- Forecasts and trends, Ceritinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines has [...]

Published
2020

19. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC) Markets to 2030 - ResearchAndMarkets.com

Subjects
Brigatinib -- Forecasts and trends -- Market share -- Reports, BCG -- Forecasts and trends -- Reports -- Market share, Crizotinib -- Reports -- Forecasts and trends, Ceritinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Company market share, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]

Published
2020

20. Non-Small Cell Lung Cancer Therapeutics Market to reach US$ 43,713.1 Mn, Growing Adoption of Targeted Therapy for Diagnosis to Boost the Market, says Fortune Business Insights

Subjects
Durvalumab -- Reports -- Market size -- Forecasts and trends, Osimertinib -- Forecasts and trends -- Reports, Atezolizumab -- Reports -- Market size -- Forecasts and trends, Bevacizumab -- Reports -- Forecasts and trends -- Market size, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Market trend/market analysis, Business, international, Law
Abstract

(GlobeNewswire) - The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small cell lung cancer. According to [...]

Published
2020

21. Non-Small Cell Lung Cancer Therapeutics Market to reach US$ 43,713.1 Mn, Growing Adoption of Targeted Therapy for Diagnosis to Boost the Market, says Fortune Business Insights

Subjects
Eli Lilly and Co. -- Forecasts and trends, Durvalumab -- Reports -- Market size -- Forecasts and trends, Osimertinib -- Forecasts and trends -- Reports, Atezolizumab -- Reports -- Market size -- Forecasts and trends, Bevacizumab -- Reports -- Forecasts and trends -- Market size, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Pune, June 08, Jun 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted [...]

Published
2020

22. Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030

Subjects
Cabozantinib -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, German foreign relations, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - [...]

Published
2020

23. BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2020

24. Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030 - ResearchAndMarkets.com

Subjects
Cabozantinib -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, German foreign relations, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2020

25. BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Squamous cell carcinoma -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the [...]

Published
2020

26. Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030

Subjects
Cabozantinib -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, German foreign relations, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 4, 2020-: Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:04062020 The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) [...]

Published
2020

27. BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 4, 2020-: BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:04062020 The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology [...]

Published
2020

28. Global Tissue Diagnostics Market (2020 to 2025) - Growing Demand for Personalized Medicines Presents Opportunities

Subjects
Precision medicine -- Forecasts and trends -- Reports, Cancer screening -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Biological products -- Supply and demand, Breast cancer, Cancer diagnosis, Cancer research, End users, Cancer, Tumors, Diseases, Medium term notes, Antibodies, Technology, Hospitals, Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease [...]

Published
2020

29. Global Tissue Diagnostics Market (2020 to 2025) - Growing Demand for Personalized Medicines Presents Opportunities

Subjects
Precision medicine -- Forecasts and trends -- Reports, Cancer screening -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Biological products -- Supply and demand, Breast cancer, Cancer diagnosis, Cancer research, End users, Cancer, Tumors, Diseases, Medium term notes, Antibodies, Technology, Hospitals, Lung cancer, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, May 25, May 25, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), [...]

Published
2020

30. Non-Small Cell Lung Cancer Market Insights, Epidemiology and Market Forecast-2030

Subjects
Merck KGaA -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Brigatinib -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Cobimetinib -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Romiplostim -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Antineoplastic agents -- Reports -- Forecasts and trends, Canakinumab, Necitumumab, Cabozantinib, Cemiplimab, Lorlatinib, Lung cancer, Avelumab, Trametinib, Vemurafenib, Larotrectinib, Dabrafenib, Atezolizumab, Binimetinib, Dacomitinib, Profits, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 20, 2020-: Non-Small Cell Lung Cancer Market Insights, Epidemiology and Market Forecast-2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:20052020 DelveInsight's 'Non-Small Cell Lung Cancer Market Insights, Epidemiology and Market Forecast - [...]

Published
2020

31. Insights into the Worldwide C-Met Mutated Non-small Cell Lung Cancer Industry to 2030 - Key Growth Opportunities

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Stem cells, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: -The 'Cellular-Mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030' report has been added [...]

Published
2020

32. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Epidemiology Forecast to 2030' report has been added to [...]

Published
2020

33. Global Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Market Insights, Epidemiology and Market Forecast to 2030

Subjects
BCG -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Dacomitinib, Lung cancer, Profits, Market trend/market analysis, Business, international, Law
Abstract

(GlobeNewswire) - The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]

Published
2020

34. Global Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer Market - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Non-Hodgkin's lymphomas, Tumors, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030' report has been added to [...]

Published
2020

35. Insights into the Worldwide BRAF Mutated Non-Small Cell Lung Cancer (2018 to 2030) - Organize Sales and Marketing Efforts by Identifying the Best Opportunities

Subjects
Dabrafenib -- Reports -- Forecasts and trends, Marketing -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Trametinib -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

36. Insights into the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market (2017 to 2030) - Featuring AstraZeneca, Pfizer & Takeda Among Others - ResearchAndMarkets.com

Subjects
Novartis Pharma AG -- Forecasts and trends, Osimertinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Dacomitinib, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]

Published
2020

37. Insights into the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market (2017 to 2030) - Featuring AstraZeneca, Pfizer & Takeda Among Others

Subjects
Osimertinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Dacomitinib, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 14, 2020-: Insights into the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market (2017 to 2030) - Featuring AstraZeneca, Pfizer & Takeda Among Others (C)1994-2020 M2 COMMUNICATIONS [...]

Published
2020

38. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 14, 2020-: Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer - Epidemiology Forecast to 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:14052020 The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer [...]

Published
2020

39. Insights into the Worldwide C-Met Mutated Non-small Cell Lung Cancer Industry to 2030 - Key Growth Opportunities

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Stem cells, Lung cancer, Diseases, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 14, 2020-: Insights into the Worldwide C-Met Mutated Non-small Cell Lung Cancer Industry to 2030 - Key Growth Opportunities (C)1994-2020 M2 COMMUNICATIONS RDATE:14052020 The 'Cellular-Mesenchymal Epithelial Transition Factor [...]

Published
2020

40. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer - Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding [...]

Published
2020

41. Insights into the Worldwide C-Met Mutated Non-small Cell Lung Cancer Industry to 2030 - Key Growth Opportunities - ResearchAndMarkets.com

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Stem cells, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Cellular-Mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth [...]

Published
2020

42. Global Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Market Insights, Epidemiology and Market Forecast to 2030

Subjects
BCG -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Dacomitinib, Lung cancer, Profits, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, May 14, May 14, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines [...]

Published
2020

43. Insights into the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market (2017 to 2030) - Key Growth Opportunities

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, May 14, May 14, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Epidemiology Forecast to 2030' report has been added [...]

Published
2020

44. Global Cellular-Mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, May 14, May 14, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Cellular-Mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030' report has been [...]

Published
2020

45. Insights into the Worldwide Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) Industry to 2030 - Key Growth Opportunities

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Non-Hodgkin's lymphomas, Tumors, Lung cancer, Diseases, Market trend/market analysis, Business, international, Law
Abstract

(GlobeNewswire) - The 'Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding [...]

Published
2020

46. Non-Small Cell Lung Cancer (NSCLC) Market Forecasts to 2030: A Comprehensive Insight

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to [...]

Published
2020

47. Insights into the Worldwide BRAF Mutated Non-Small Cell Lung Cancer (2018 to 2030) - Organize Sales and Marketing Efforts by Identifying the Best Opportunities - ResearchAndMarkets.com

Subjects
Dabrafenib -- Reports -- Forecasts and trends, Marketing -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Trametinib -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers [...]

Published
2020

48. Global Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer Market - Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Squamous cell carcinoma -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Non-Hodgkin's lymphomas, Tumors, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding [...]

Published
2020

49. Insights into the Worldwide Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) Industry to 2030 - Key Growth Opportunities

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Non-Hodgkin's lymphomas, Tumors, Lung cancer, Diseases, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, May 13, May 13, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030' report has been added [...]

Published
2020

50. Global BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast to 2030

Subjects
Dabrafenib -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Trametinib -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, May 13, May 13, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results